etizolam and carbamazepine

etizolam has been researched along with carbamazepine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Aoshima, T; Fukasawa, T; Inoue, Y; Kondo, S; Otani, K; Suzuki, A; Tateishi, T; Yasui-Furukori, N	1

Trials

1 trial(s) available for etizolam and carbamazepine

Article	Year
Induction of the metabolism of etizolam by carbamazepine in humans. European journal of clinical pharmacology, 2005, Volume: 61, Issue:3 Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Half-Life; Humans; Male; Metabolic Clearance Rate; Tranquilizing Agents	2005

Article

Year

Induction of the metabolism of etizolam by carbamazepine in humans.

European journal of clinical pharmacology, 2005, Volume: 61, Issue:3

Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Half-Life; Humans; Male; Metabolic Clearance Rate; Tranquilizing Agents

2005

Other Studies

2 other study(ies) available for etizolam and carbamazepine

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010